Literature DB >> 21561727

Diagnostic markers in combination improve the identification of growth-restricted neonates.

Popi Sifianou1, Vasso Ktena, Helen Karga.   

Abstract

BACKGROUND: The identification of growth-restricted neonates is hampered by the lack of an appropriate diagnostic tool. AIM: To determine the value of combining diagnostic markers in detecting growth-restricted neonates.
METHODS: A set of anthropometric indices, nutritional status and placental weight were assessed in the study population soon after birth. Insulin-like growth factor I (IGF-I) and its binding protein 3 (IGFBP-3) were assayed in cord blood. Babies having low values (≤25th centile for gestational age) in 0, 1 or more of four anthropometric indices were classified as Group(25)0, Group(25)1 and Group(25)2, respectively. For statistical evaluation the Mann-Whitney test and a multiple regression analysis were performed.
RESULTS: One hundred-eighty (180) singleton babies of over 36 weeks of gestational age (GA) were studied. IGF-I, IGFBP-3 levels and placental weight were significantly lower in Group(25)2 than both Group(25)0 (P<0.0001) and Group(25)1 (p<0.0001 to p = 0.03). Group(25)1 and Group(25)0 did not differ significantly regarding IGF-I and IGFBP-3 levels (p values 0.09 and 0.13, respectively). The combination of anthropometric indices enhanced their ability to predict IGF-I, IGFBP-3 levels and placental weight; the nutritional status of the babies added power to all individual models in predicting the three outcome variables. Analogous results were obtained when the 10th (instead of the 25th) centile for GA was used for the anthropometric indices.
CONCLUSION: The combination of simple diagnostic markers of growth restriction can define a reference test with enhanced diagnostic potential compared to the potential of the same markers in isolated use.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21561727     DOI: 10.1016/j.earlhumdev.2011.04.011

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  1 in total

1.  Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation.

Authors:  Popi Sifianou; Voula Thanou; Helen Karga
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Mar-Apr
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.